image

The best stocks to buy since 1993

Latest issue now available

Emis - Rollout of EMISWeb accelerates

September 2012

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • EMIS
  • Price:
  • 715p
EMIS, the UK's supplier of software and related services to GPs, has been a shooting star for the Sharewatch Growth Portfolio. During the month the company reported H1 which came in ahead of expectations. The roll-out of the new internet based system EMISWeb accelerated as expected and at the end of June, there were 747 live EMIS Web practices whilst a further 215 have gone live since June. In addition, there are 1385 unfulfilled orders received (and also 2753 “familiarisation contracts†where GPs use the system on a read only basis) and by October the number of practices going live will reach 200 new each month. What does this mean? It means that typically per practice the income on EMISWeb rises from £9,500 to £12,500 as a ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe